Acoustic Cardiographic Assessment of Heart Function in Comparison to Doppler-echocardiography
NCT ID: NCT00541801
Last Updated: 2011-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2007-03-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acoustic Cardiographic Assessment of Heart Function and the Role of Phrenic Nerve Stimulation
NCT00541541
Characterization of Arrhythmia-induced Cardiomyopathy
NCT05662293
Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy
NCT03450252
Risk of Pacing-induced Cardiomyopathy
NCT04269733
Right Ventricular Septal Versus Apical Pacing: Echocardiographic Study
NCT06045143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Doppler-echocardiography and acoustic cardiography
Patients receive a Doppler-echocardiography and an acoustic cardiography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inovise Medical
INDUSTRY
Luzerner Kantonsspital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kantonsspital Luzern
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Erne, MD
Role: STUDY_CHAIR
Luzerner Kantonsspital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kantonsspital Luzern, Department of Cardiology
Lucerne, Canton of Lucerne, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Audicor-Oncology
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.